. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Aliment Pharmacol Ther. 2017 Jul 10;46(6):581–588. doi: 10.1111/apt.14214

Table 1.

Demographics, psychosomatic scores and quantitative data on bile acid diarrhoea serum markers (BSFS: Bristol Stool Form Scale; HAD: Hospital Anxiety and Depression Scale)

Mean ± SD	IBS-D/Chronic diarrhoea
N	101
IBS-D/functional diarrhoea	84 / 17
Age (yrs)	42.2 ± 12.9
Gender (F/M)	85/16
BMI, kg/m²	28.7 ± 7.4
Bowel movements/day	2.2 ± 1.2
Bowel consistency (BSFS)	4.7 ± 1.0
Anxiety score (HAD)	4.5 ± 2.9
Depression score (HAD)	1.6 ± 1.7
Abdominal surgery (# of patients)
Hysterectomy	13
Cholecystectomy	14
Appendectomy	10
Fasting serum C4 (ng/mL)	23.5 ± 23.1
Number with C4 ≥52.5ng/mL	10/101 (10%)
Fasting serum FGF19 (pg/mL)	121.6 ± 84.22
Number with FGF19 ≤61.7pg/mL	21/100 (21%)